HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshihisa Yano Selected Research

6-O-carboxypropyl-alpha-tocotrienol

1/2008A redox-silent analogue of tocotrienol inhibits hypoxic adaptation of lung cancer cells.
7/2005Induction of cytotoxicity in human lung adenocarcinoma cells by 6-O-carboxypropyl-alpha-tocotrienol, a redox-silent derivative of alpha-tocotrienol.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshihisa Yano Research Topics

Disease

5Neoplasms (Cancer)
01/2008 - 02/2002
3Chronic Hepatitis C
03/2003 - 01/2002
2Lung Neoplasms (Lung Cancer)
01/2008 - 07/2005
2Hepatocellular Carcinoma (Hepatoma)
03/2003 - 03/2002
1Mesothelioma
05/2009
1Hypoxia (Hypoxemia)
01/2008
1Lissencephaly
11/2005
1Adenocarcinoma of Lung
07/2005
1Polycystic Kidney Diseases (Polycystic Kidney Disease)
06/2003
1Hepatitis B
06/2003
1Chronic Hepatitis B
06/2003
1Cysts
06/2003
1Autosomal Dominant Polycystic Kidney (ADPKD)
06/2003
1Anaplastic Thyroid Carcinoma
12/2002
1Hypertension (High Blood Pressure)
09/2002
1Retinoblastoma (Glioblastoma, Retinal)
05/2002
1Liver Cirrhosis (Hepatic Cirrhosis)
03/2002
1Chronic Hepatitis (Chronic Active Hepatitis)
03/2002
1Hepatitis
03/2002
1Fibrosis (Cirrhosis)
03/2002
1Ehrlich Tumor Carcinoma
02/2002
1Infections
02/2002
1Autoimmune Hepatitis
02/2002

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
11/2005 - 01/2002
3EnzymesIBA
09/2002 - 01/2002
2TocotrienolsIBA
05/2009 - 01/2008
26-O-carboxypropyl-alpha-tocotrienolIBA
01/2008 - 07/2005
2alpha tocotrienolIBA
01/2008 - 07/2005
2InterferonsIBA
03/2003 - 01/2002
2PolyaminesIBA
09/2002 - 03/2002
2RNA (Ribonucleic Acid)IBA
03/2002 - 02/2002
1Cytotoxins (Cytolysins)IBA
05/2009
1PlasminogenIBA
01/2008
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2008
1KataninIBA
11/2005
1Cytoplasmic DyneinsIBA
11/2005
1alpha-TocopherolFDA Link
07/2005
1Antineoplastic Agents (Antineoplastics)IBA
07/2005
1PPAR deltaIBA
07/2005
14- (3- (2- propyl- 3- hydroxy- 4- acetyl)phenoxy)propyloxyphenoxy acetic acidIBA
07/2005
1ProstaglandinsIBA
07/2005
1Lamivudine (Epivir)FDA Link
06/2003
1TRPP Cation ChannelsIBA
06/2003
1HLA Antigens (Human Leukocyte Antigens)IBA
03/2003
1LigandsIBA
12/2002
1PPAR gammaIBA
12/2002
1Cytostatic AgentsIBA
12/2002
1PutrescineIBA
09/2002
1SaltsIBA
09/2002
1Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA
09/2002
1SpermidineIBA
09/2002
1SpermineIBA
09/2002
1Sulfhydryl Compounds (Thiols)IBA
05/2002
1PolyphenolsIBA
05/2002
1TeaIBA
05/2002
1gallocatechol (epigallocatechin)IBA
05/2002
1Retinoblastoma ProteinIBA
05/2002
1Tyrosine (L-Tyrosine)FDA Link
02/2002
1Acetates (Acetic Acid Esters)FDA Link
02/2002
11'-acetoxychavicol acetateIBA
02/2002
1AntibodiesIBA
02/2002
1DNA (Deoxyribonucleic Acid)IBA
02/2002
1ImmunosorbentsIBA
02/2002
1Antiviral Agents (Antivirals)IBA
01/2002

Therapy/Procedure

4Therapeutics
06/2003 - 01/2002